Your browser doesn't support javascript.
loading
Potential Opportunities and Challenges of Deploying Next Generation Sequencing and CRISPR-Cas Systems to Support Diagnostics and Surveillance Towards Malaria Control and Elimination in Africa.
Lyimo, Beatus M; Popkin-Hall, Zachary R; Giesbrecht, David J; Mandara, Celine I; Madebe, Rashid A; Bakari, Catherine; Pereus, Dativa; Seth, Misago D; Ngamba, Ramadhan M; Mbwambo, Ruth B; MacInnis, Bronwyn; Mbwambo, Daniel; Garimo, Issa; Chacky, Frank; Aaron, Sijenunu; Lusasi, Abdallah; Molteni, Fabrizio; Njau, Ritha; Cunningham, Jane A; Lazaro, Samwel; Mohamed, Ally; Juliano, Jonathan J; Bailey, Jeffrey A; Ishengoma, Deus S.
Affiliation
  • Lyimo BM; National Institute for Medical Research, Dar es Salaam, Tanzania.
  • Popkin-Hall ZR; School of Life Sciences and Bio-Engineering, Nelson Mandela African Institution of Science and Technology, Arusha, Tanzania.
  • Giesbrecht DJ; School of Medicine, University of North Carolina, Chapel Hill, NC, United States.
  • Mandara CI; Pathology and Laboratory Medicine, Center for International Health Research, Brown University, Providence, RI, United States.
  • Madebe RA; National Institute for Medical Research, Dar es Salaam, Tanzania.
  • Bakari C; National Institute for Medical Research, Dar es Salaam, Tanzania.
  • Pereus D; National Institute for Medical Research, Dar es Salaam, Tanzania.
  • Seth MD; National Institute for Medical Research, Dar es Salaam, Tanzania.
  • Ngamba RM; National Institute for Medical Research, Dar es Salaam, Tanzania.
  • Mbwambo RB; National Institute for Medical Research, Dar es Salaam, Tanzania.
  • MacInnis B; National Institute for Medical Research, Dar es Salaam, Tanzania.
  • Mbwambo D; Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, United States.
  • Garimo I; Infectious Disease and Microbiome Program, Broad Institute, Boston, MA, United States.
  • Chacky F; National Malaria Control Programme, Dodoma, Tanzania.
  • Aaron S; National Malaria Control Programme, Dodoma, Tanzania.
  • Lusasi A; National Malaria Control Programme, Dodoma, Tanzania.
  • Molteni F; National Malaria Control Programme, Dodoma, Tanzania.
  • Njau R; National Malaria Control Programme, Dodoma, Tanzania.
  • Cunningham JA; Swiss Tropical Public Health Institute, Dar es Salaam, Tanzania.
  • Lazaro S; World Health Organization, Country Office, Dar es Salaam, Tanzania.
  • Mohamed A; Global Malaria Programme, World Health Organization, Headquarters, Geneva, Switzerland.
  • Juliano JJ; National Malaria Control Programme, Dodoma, Tanzania.
  • Bailey JA; National Malaria Control Programme, Dodoma, Tanzania.
  • Ishengoma DS; School of Medicine, University of North Carolina, Chapel Hill, NC, United States.
Front Cell Infect Microbiol ; 12: 757844, 2022.
Article in En | MEDLINE | ID: mdl-35909968
ABSTRACT
Recent developments in molecular biology and genomics have revolutionized biology and medicine mainly in the developed world. The application of next generation sequencing (NGS) and CRISPR-Cas tools is now poised to support endemic countries in the detection, monitoring and control of endemic diseases and future epidemics, as well as with emerging and re-emerging pathogens. Most low and middle income countries (LMICs) with the highest burden of infectious diseases still largely lack the capacity to generate and perform bioinformatic analysis of genomic data. These countries have also not deployed tools based on CRISPR-Cas technologies. For LMICs including Tanzania, it is critical to focus not only on the process of generation and analysis of data generated using such tools, but also on the utilization of the findings for policy and decision making. Here we discuss the promise and challenges of NGS and CRISPR-Cas in the context of malaria as Africa moves towards malaria elimination. These innovative tools are urgently needed to strengthen the current diagnostic and surveillance systems. We discuss ongoing efforts to deploy these tools for malaria detection and molecular surveillance highlighting potential opportunities presented by these innovative technologies as well as challenges in adopting them. Their deployment will also offer an opportunity to broadly build in-country capacity in pathogen genomics and bioinformatics, and to effectively engage with multiple stakeholders as well as policy makers, overcoming current workforce and infrastructure challenges. Overall, these ongoing initiatives will build the malaria molecular surveillance capacity of African researchers and their institutions, and allow them to generate genomics data and perform bioinformatics analysis in-country in order to provide critical information that will be used for real-time policy and decision-making to support malaria elimination on the continent.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Communicable Diseases / Malaria Type of study: Diagnostic_studies / Prognostic_studies / Screening_studies Limits: Humans Country/Region as subject: Africa Language: En Journal: Front Cell Infect Microbiol Year: 2022 Document type: Article Affiliation country: Tanzania

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Communicable Diseases / Malaria Type of study: Diagnostic_studies / Prognostic_studies / Screening_studies Limits: Humans Country/Region as subject: Africa Language: En Journal: Front Cell Infect Microbiol Year: 2022 Document type: Article Affiliation country: Tanzania